Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: Relevance to stress and interaction with vasopressin

Stress

Volumn 11, Issue 4, 2008, Pages 290-301

  Cudnoch Jedrzejewska, Agnieszka ^a   Szczepanska Sadowska, Ewa ^a   Dobruch, Jakub ^a   Puchalska, Liana ^a   Ufnal, Marcin ^a   Kowalewski, Stanislaw ^a   Wsół, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Air jet stress; Alarming stress; Angiotensin; Heart failure; V1 antagonist; Vasopressin

Indexed keywords

ANGIOTENSIN II; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE ASSOCIATION; DRUG EFFECT; HEART FAILURE; HEART INFARCTION; HEART SURGERY; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STRESS;

ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; HEART RATE; INJECTIONS, INTRAVENTRICULAR; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; STRESS; VASOPRESSINS;

EID: 46049113890     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890701794445     Document Type: Article

References (55)

1. Armando I, Terron JA, Falcon-Neri A, Takeshi I, Hauser W, Inagami T, Saavedra JM. 2002. Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice. Neuroendocrinology 76:137-147.
2. Bottari SP, De Gasparo M, Steckelings UM, Levens NR. 1993. Angiotensin II receptor subtypes: Characterization, signalling, mechanisms, and possible physiological implications. Front Neuroendocrinol 14:123-171.
3. Braszko JJ. 2002. AT2 but not AT1 receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats. Behav Brain Res 131:79-86.
4. Cameron V, Espiner EA, Nicholls MG, Donald RA, Mac Farlane MR. 1985. Stress hormones in blood and cerebrospinal fluid of conscious sheep: Effect of hemorrhage. Endocrinology 116:1460-1465.
5. Carrasco GA, Van de Kar LD. 2003. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235-272.
6. Cowley AW, Jr., Quillen EW, Jr., Skelton MM. 1983. Role of vasopressin in cardiovascular regulation. Fed Proc 42:3170-3176.
7. Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E, Dobruch J, Morton M, Koperski Ł, Wasiutynski A, Wsół A, Kowalewski S. 2005. Fluid consumption, electrolyte excretion and heart remodeling in rats with myocardial infarct maintained on regular and high sodium intake. J Physiol Pharmacol 56:599-610.
8. Cudnoch-Jedrzejewska A, Dobruch J, Puchalska L, Szczepanska-Sadowska E. 2007. Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state. Regul Pept 142:86-94.
9. Curran-Everett D, Benos DJ. 2004. Guidelines for reporting statistics in journals published by the American Physiological Society. Physiol Genomics 18:249-251.
10. Demotes-Mainard J, Chauveau J, Rodriguez F, Vincent JD, Poulain DA. 1986. Septal release of vasopressin in response to osmotic, hypovolemic and electrical stimulation in rats. Brain Res 381:314-321.
11. DiBona GF. 1999. Central sympathoexcitatory actions of angiotensin II: Role of type 1 angiotensin II receptors. J Am Soc Nephrol 11:S90-S94.
12. Dobruch J, Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E. 2005. Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction. Stress 8:273-284.
13. Dumont EC, Rafrafi S, Laforest S, Drolet G. 1999. Involvement of central angiotensin receptors in stress adaptation. Neuroscience 93:877-884.
14. Fitzsimons JT. 1979. The physiology of thirst and sodium appetite. Cambridge: Cambridge University Press. p 128-265.
15. Francis J, Zhang ZH,Weiss RM, Felder R. 2004. Neural regulation of the proinflamatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol 287:H791-H797.
16. Ganten D, Unger T, Lang RE. 1985. The dual role of angiotensin and vasopressin as plasma hormones and neuropeptides in cardiovascular regulation. J Pharmacol 16(suppl II):51-68.
17. Haack D, Mocombining double acute accenthring J. 1978. Vasopressin-mediated blood pressure response to intraventricular injection of angiotensin II in the rat. Pflügers Arch 373:167-173.
18. Hogarty DC, Tran DN, Phillips MI. 1994. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin. Brain Res 637:126-132.
19. Janiak P, Kasson BG, Brody MJ. 1989. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release. Hypertension 13:935-940.
20. Kagiyama S, Varela A, Phillips MI, Galli SM. 2001. Antisense inhibition of brain rennin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension 37:371-375.
21. Kovacs KJ, Sawchenko PE. 1996. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 16:262-273.
22. Kubo T, Yamaguchi H, Tsujimura M, Hagiwara Y, Fukumori R. 2000. Angiotensin system in the anterior hypothalamic area is involved in the maintenance of hypertension in spontaneously hypertensive rats. Brain Res Bull 52:291-296.
23. Landgraf R. 2006. The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5:167-179.
24. Lee MA, Bohm M, Paul M, Bader M, Ganten U, Ganten D. 1996. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 270:E919-E929.
25. Leenen FHH, Yuan B, Huang BS. 1999. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 277:H1786-H1792.
26. Łoń S, Szczepańska-Sadowska E, Szczypaczewska M. 1996. Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II. Am J Physiol Heart Circ Physiol 270:H167-H173.
27. Ludbrook J. 1994. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303-311.
28. Martin SM,Malkinson TJ, Veale WL, Pittman QJ. 1985. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbits. Brain Res 348:137-145.
29. Mayorov DN, Head GA. 2003. AT1 receptors in the RVLM mediate pressor responses to emotional stress in rabbits. Hypertension 41:1168-1173.
30. Mayorov DN, Head GA, De Matteo R. 2004. Tempol attenuates excitatory actions of angiotensin II in the rostral ventrolateral medulla during emotional stress. Hypertension 44:101-106.
31. Muders F, Riegger GA, Bahner U, Palkovits M. 2002. The central vasopressinergic system in experimental left ventricular hypertrophy and dysfunction. Prog Brain Res 139:275-279.
32. Noszczyk B, Łoń S, Szczepańska-Sadowska E. 1993. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and "V3" agonistic or antagonistic properties in conscious dog. Brain Res 610:115-126.
33. Paczwa P, Budzikowski AS, Szczepańska-Sadowska E. 1997. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial N(G)-nitro-L-arginine. Brain Res 748:51-61.
34. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
35. Pittman QJ, Lawrence D, McLean L. 1982. Central effects of arginine vasopressin on blood pressure in rats. Endocrinology 110:1058-1060.
36. Robinson MM, McLean GP, Thurnhorst RL, Johnson AK. 1999. Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses. Brain Res 842:55-61.
37. Saad WA, Camargo LA. 2003. Influence of angiotensin II receptor subtypes of the paraventricular nucleus on the physiological responses induced by angiotensin II injection into the medial septal area. Arq Bras Cardiol 80:396-405.
38. Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, Juorio A, Macova M. 2005. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept 128:227-238.
39. Saavedra JM, Armando I, Bregonzio C, Juorio A, Macova M, Pavel J, Sanchez-Lemus E. 2006. A centrally acting anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology 31:1123-1134.
40. Selye H, Bajusz E, Grasso S, Mendell P. 1960. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11:398-407.
41. Szczepanska-Sadowska E. 2006. Neuropeptides in neurogenic disorders of the cardiovascular control. J Physiol Pharmacol 57(suppl 11):31-59.
42. Szczepanska-Sadowska E, Gray D, Simon-Oppermann C. 1983. Vasopressin in blood and third ventricle CSF during dehydration, thirst, and hemorrhage. Am J Physiol 245:R549-R555.
43. Szczepanska-Sadowska E, Paczwa P, Łoń S, Ganten D. 1998. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats. J Hypertens 16:1505-1514.
44. Tan J, Wang H, Leenen FHH. 2004. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286:H1665-H1671.
45. Toney GM, Porter JP. 1993. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats. Neuropharmacology 32:581-589.
46. Ufnal M, Dudek M, Żera T, Szczepanska-Sadowska E. 2006. Centrally administered interleukin-1beta sensitizes to the central pressor action of angiotensin II. Brain Res 1100:64-72.
47. Veltmar A, Culman J, Qadri F, Rascher W, Unger T. 1992. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther 263:1253-1260.
48. Wang W, Ma R. 2000. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev 5:57-71.
49. Winer BJ, Brown DR, Michels KM. 1991. Statistical principles in experimental Design. New York: McGraw-Hill, Inc. p 1-1057.
50. Wright J, Harding JW. 1998. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 18:21-53.
51. Wright J, Harding JW. 2004. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning and memory. Progr Neurobiol 72:263-293.
52. Żera T, Ufnal M, Szczepanska-Sadowska E. 2006. Tumor necrosis factor-alpha sensitizes to pressor action of centrally administered angiotensin II. J Physiol Pharmacol 57(suppl 2):253.
53. Zhang W, Huang BS, Leenen FHH. 1999. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 276:H1608-H1615.
54. Zhu GQ, Gao L, Patel KP, Zucker IH, Wang W, Zucker IH, Wang W. 2004. ANGII in the paraventricular nucleus potentates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl Physiol 97:1746-1754.
55. Zucker IH, Schultz HD, Li Y-F, Wang Y, Wang W, Patel KP. 2004. The origin of sympathetic outflow in heart failure: The role of angiotensin II and nitric oxide. Progr Biophys Mol Biol 84:217-232.